October 2020 - Global Life Science Business Partnering - News & Updates
Highlights of October 2020
- Aurobindo Pharma Signs Pact to Sell U.S. Unit Natrol to New Mountain Capital and its affiliate Jarrow Formulas in an all cash transaction of US$550 Million.
- Alembic Pharma inks oncology deal for US$149.5 Million with Curon Biopharma.
- IAVI, Merck, Serum Institute of India partner to develop mAbs against COVID-19.
- Aurobindo Pharma to acquire 100% stake in MViyeS Pharma Ventures.
- Epygen Biotech partners with Dyadic International for COVID-19 vaccine development.
- Bharat Biotech inks deal with ViroVax for adjuvant to Covaxin.
- NephroPlus, Hyderabad has acquired a majority stake in Royal Care Dialysis Centers, Inc (RCDC), a reputed dialysis network in the Philippines with a deep focus in delivering high-quality care.
- Medicure inks agreement with Reliance LS for marketing cardiovascular biosimilar.
- Mumbai based PAG, along with consortium partners CX Partners and Samara Capital, had reached an agreement to acquire a controlling stake in Anjan Drug Pvt. Ltd., a Chennai-based manufacturer of active pharmaceutical ingredients (API).
- SK Biopharm signs US$503 million deal to commercialize anti-epileptic drug in Japan.
- Mubadala Investment Company and Novo Holdings A/S invest € 250 million in Evotec SE.
- Locus Biosciences signs $144 million contract with BARDA to develop LBP-EC01
- Vaxart inks manufacturing pact with Kindred Bio for oral vaccines to battle COVID-19, other viruses.
- Novo Nordisk buys into Chugai's antibody engineering expertise.
Highlights at Aagami:
- Aagami successfully completed Digital BIO-Europe® 2020 (October 26–29, 2020) with more than 30 one-on-one virtual meetings.
- Aagami to attend JPM week and Biotech Showcase virtually in January 2021. Partnering opens November 23, 2020.
- Aagami, along with its associate partner, successfully delivered a Regulatory Report project to its Portugal based pharma client.
- Aagami enhances its operations in Europe via partnership with Germany based Azeta Pharma.
- IMPORTANT: Our Office address is reverted to 2020 Calamos Court, Suite 200, Naperville IL 60563 USA. It is just across the road from the earlier address. Kindly make a note of it.